Search results
China Approves AstraZeneca's Tagrisso-Chemotherapy Combo Regime For Previously Untreated Lung Cancer...
Benzinga via Yahoo Singapore Finance· 2 weeks agoOn Wednesday, China approved AstraZeneca plc's (NYSE:AZN) Tagrisso (osimertinib) with the addition...
China approves AstraZeneca's Tagrisso-chemo combo as first-line treatment
Reuters via Yahoo Singapore Finance· 2 weeks agoAstraZeneca said the approval by China's National Medical Products Administration (NMPA) was based...
The secrets of success with Paul Hudson, CEO of Sanofi, the leader who’s channeling AI to find the...
Fortune via Yahoo Singapore Finance· 2 weeks agoCEO Agenda provides unique insights into how leaders think and lead and what keeps them busy in a...
FTSE 100 Live 19 June: UK inflation hits Bank of England's 2% target, blue-chips slightly lower
Evening Standard via Yahoo Singapore Finance· 3 weeks agoThe UK’s inflation rate today slowed to 2%, its lowest level in almost three years. Despite the...
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
Benzinga via Yahoo Singapore Finance· 3 weeks agoAstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug...
FTSE 100 Live 3 June: New York trading glitch sparks volatility, GSK shares tumble
Evening Standard via Yahoo Singapore Finance· 1 month agoGSK shares are today’s major focus after the drugs giant’s defence against Zantac claims suffered a...
18 Cities in the World Where the Biggest Companies Are Headquartered
GOBankingRates via Yahoo Singapore Finance· 1 month agoThe locations of companies that generate billions and trillions of dollars aid economic growth and...
British firms expecting hard time in China market, lobby group warns
Reuters via Yahoo Singapore Finance· 2 months agoBritish firms expect doing business in China to become harder over the next five years, a British...
AstraZeneca aims for $80 billion in total revenue by 2030
Reuters via Yahoo Singapore Finance· 2 months agoAstraZeneca aims to grow revenue by about 75% to $80 billion by 2030, it said on Tuesday, boosted by...
UPDATE 3-AstraZeneca to build $1.5-bln cancer drug plant in Singapore
Reuters SG via Yahoo Singapore Finance· 2 months agoAstraZeneca plans to build a $1.5 billion manufacturing facility in Singapore to produce a promising category of cancer-killing drugs called antibody-drug conjugates (ADCs), the Anglo-Swedish ...